First Time Loading...
E

Excelsior Medical Co Ltd
TWSE:4104

Watchlist Manager
Excelsior Medical Co Ltd
TWSE:4104
Watchlist
Price: 90.7 TWD 0.33% Market Closed
Updated: May 17, 2024

Profitability Summary

50/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Excelsior Medical Co Ltd

Revenue
8.2B TWD
Cost of Revenue
-6.6B TWD
Gross Profit
1.7B TWD
Operating Expenses
-966.8m TWD
Operating Income
702.9m TWD
Other Expenses
43.7m TWD
Net Income
746.6m TWD

Margins Comparison
Excelsior Medical Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
TW
Excelsior Medical Co Ltd
TWSE:4104
14.1B TWD
20%
9%
9%
US
Mckesson Corp
NYSE:MCK
72.2B USD
4%
1%
1%
US
Cencora Inc
NYSE:COR
44.2B USD
3%
1%
1%
US
Amerisourcebergen Corp
NYSE:ABC
35.4B USD
3%
1%
1%
US
Cardinal Health Inc
NYSE:CAH
24.1B USD
3%
1%
0%
US
Henry Schein Inc
NASDAQ:HSIC
9.5B USD
31%
5%
3%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
30%
9%
7%
CN
Sinopharm Group Co Ltd
HKEX:1099
68.3B HKD
8%
4%
2%
IT
Amplifon SpA
MIL:AMP
7.7B EUR
65%
12%
7%
CN
Huadong Medicine Co Ltd
SZSE:000963
57.7B CNY
32%
9%
7%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
52.6B CNY
11%
3%
1%
Country TW
Market Cap 14.1B TWD
Gross Margin
20%
Operating Margin
9%
Net Margin
9%
Country US
Market Cap 72.2B USD
Gross Margin
4%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 44.2B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 35.4B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 24.1B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
0%
Country US
Market Cap 9.5B USD
Gross Margin
31%
Operating Margin
5%
Net Margin
3%
Country KR
Market Cap 12.2T KRW
Gross Margin
30%
Operating Margin
9%
Net Margin
7%
Country CN
Market Cap 68.3B HKD
Gross Margin
8%
Operating Margin
4%
Net Margin
2%
Country IT
Market Cap 7.7B EUR
Gross Margin
65%
Operating Margin
12%
Net Margin
7%
Country CN
Market Cap 57.7B CNY
Gross Margin
32%
Operating Margin
9%
Net Margin
7%
Country CN
Market Cap 52.6B CNY
Gross Margin
11%
Operating Margin
3%
Net Margin
1%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Excelsior Medical Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
TW
Excelsior Medical Co Ltd
TWSE:4104
14.1B TWD
9%
4%
6%
4%
US
Mckesson Corp
NYSE:MCK
72.2B USD
-157%
5%
27%
21%
US
Cencora Inc
NYSE:COR
44.2B USD
272%
3%
20%
15%
US
Amerisourcebergen Corp
NYSE:ABC
35.4B USD
371%
3%
18%
13%
US
Cardinal Health Inc
NYSE:CAH
24.1B USD
-20%
1%
21%
13%
US
Henry Schein Inc
NASDAQ:HSIC
9.5B USD
11%
4%
9%
6%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
7%
3%
9%
5%
CN
Sinopharm Group Co Ltd
HKEX:1099
68.3B HKD
13%
2%
17%
10%
IT
Amplifon SpA
MIL:AMP
7.7B EUR
15%
4%
11%
7%
CN
Huadong Medicine Co Ltd
SZSE:000963
57.7B CNY
15%
9%
17%
13%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
52.6B CNY
6%
2%
9%
5%
Country TW
Market Cap 14.1B TWD
ROE
9%
ROA
4%
ROCE
6%
ROIC
4%
Country US
Market Cap 72.2B USD
ROE
-157%
ROA
5%
ROCE
27%
ROIC
21%
Country US
Market Cap 44.2B USD
ROE
272%
ROA
3%
ROCE
20%
ROIC
15%
Country US
Market Cap 35.4B USD
ROE
371%
ROA
3%
ROCE
18%
ROIC
13%
Country US
Market Cap 24.1B USD
ROE
-20%
ROA
1%
ROCE
21%
ROIC
13%
Country US
Market Cap 9.5B USD
ROE
11%
ROA
4%
ROCE
9%
ROIC
6%
Country KR
Market Cap 12.2T KRW
ROE
7%
ROA
3%
ROCE
9%
ROIC
5%
Country CN
Market Cap 68.3B HKD
ROE
13%
ROA
2%
ROCE
17%
ROIC
10%
Country IT
Market Cap 7.7B EUR
ROE
15%
ROA
4%
ROCE
11%
ROIC
7%
Country CN
Market Cap 57.7B CNY
ROE
15%
ROA
9%
ROCE
17%
ROIC
13%
Country CN
Market Cap 52.6B CNY
ROE
6%
ROA
2%
ROCE
9%
ROIC
5%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More